Page last updated: 2024-09-04

cyc 202 and sb 220025

cyc 202 has been researched along with sb 220025 in 2 studies

Compound Research Comparison

Studies (cyc 202)	Trials (cyc 202)	Recent Studies (post-2010) (cyc 202)	Studies (sb 220025)	Trials (sb 220025)	Recent Studies (post-2010) (sb 220025)
979	7	393	29	0	7

Protein Interaction Comparison

Protein	Taxonomy	sb 220025 (IC50)
Chain A, MAP KINASE P38	Homo sapiens (human)	9.0095
Chain A, PROTEIN (MAP KINASE P38)	Homo sapiens (human)	9.0095
Chain A, PROTEIN (MAP KINASE P38)	Homo sapiens (human)	9.0095
Chain A, Protein (map Kinase P38)	Homo sapiens (human)	9.0095
Chain A, Extracellular Regulated Kinase 2	Rattus norvegicus (Norway rat)	9.0095
Chain A, Extracellular Regulated Kinase 2	Rattus norvegicus (Norway rat)	9.0095
Mitogen-activated protein kinase 13	Homo sapiens (human)	0.019
Mitogen-activated protein kinase 12	Homo sapiens (human)	0.019
Mitogen-activated protein kinase 1	Rattus norvegicus (Norway rat)	0.019
Mitogen-activated protein kinase 11	Homo sapiens (human)	0.019
Mitogen-activated protein kinase 14	Homo sapiens (human)	0.0193

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M	1
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ	1

Other Studies

2 other study(ies) available for cyc 202 and sb 220025

Article	Year
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51 Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases	2007
Identification of potent Yes1 kinase inhibitors using a library screening approach. Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15 Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship	2013

Article

Year

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.

Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007

Identification of potent Yes1 kinase inhibitors using a library screening approach.

Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013